Lupin completes acquisition of brands from Anglo-French
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
TIB Molbiol excels in ultra-rapid assay development for emerging infectious diseases, strongly demonstrated during the Covid-19 pandemic
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
Subscribe To Our Newsletter & Stay Updated